Abstract Details

Title Primary CNS Posttransplant Lymphoproliferative Disease (PCNS-PTLD): Recognizing the Entity and Minimizing Toxicity in Renal Transplant Patients

Topic Neuro-oncology

Presentation(s) P6 - (-)

Poster/Presentation
Number 125

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Na Tosha N. Gatson, MD, PhD, FAAN PRESENTER	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��